Basic Information
RxCell is a biotechnology company focused on the therapeutic applications of induced pluripotent stem cells (iPSCs). The company has developed several therapeutic-grade iPSC line seed banks and is in the process of manufacturing a large master cell bank to support its operations. In addition to its efforts in the therapeutic field, RxCell also sells cells, media, and other related reagents for academic and drug discovery research under its XCell brand. The company’s primary focus is providing neural and retinal lineage cells for drug discovery and research purposes.
RxCell, Inc.
California,United States of America
less than 15 people
January 01, 2012
xzeng@xcellscience.com
